Amicus Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 11/07/2025 | 29.53 M | $232.73 M | 0.43% | 9.59% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 28.63 M | $225.60 M | -1.70% | 9.30% |
| BLACKROCK, INC. | 11/12/2025 | 25.85 M | $203.69 M | -6.11% | 8.39% |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 11/12/2025 | 15.75 M | $124.10 M | 7.56% | 5.11% |
| AVORO CAPITAL ADVISORS LLC | 11/14/2025 | 15.03 M | $118.40 M | -16.53% | 4.88% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 11.81 M | $93.06 M | 59.13% | 3.83% |
| STATE STREET CORP | 11/14/2025 | 11.56 M | $91.12 M | -0.04% | 3.75% |
| VESTAL POINT CAPITAL, LP | 11/14/2025 | 9.75 M | $76.83 M | -18.07% | 3.17% |
| CITADEL ADVISORS LLC | 11/14/2025 | 8.25 M | $65.01 M | 38.09% | 2.68% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2025 | 7.16 M | $56.39 M | 118.25% | 2.32% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 7.11 M | $56.02 M | 3.82% | 2.31% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 7.10 M | $55.95 M | 5.85% | 2.31% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/18/2025 | 6.79 M | $53.62 M | 73.72% | 2.20% |
| PERCEPTIVE ADVISORS LLC | 11/14/2025 | 6.37 M | $50.20 M | -14.06% | 2.07% |
| PALO ALTO INVESTORS LP | 11/14/2025 | 5.37 M | $42.30 M | -4.33% | 1.74% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 11/14/2025 | 4.69 M | $36.96 M | 100.00% | 1.52% |
| NUVEEN, LLC | 11/12/2025 | 4.62 M | $36.42 M | 27.28% | 1.50% |
| MACQUARIE GROUP LTD | 11/13/2025 | 4.56 M | $35.94 M | -40.94% | 1.48% |
| D. E. SHAW & CO., INC. | 11/14/2025 | 3.87 M | $30.48 M | -39.20% | 1.26% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 3.78 M | $29.82 M | -12.86% | 1.23% |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 10/29/2025 | 3.71 M | $29.22 M | -0.48% | 1.20% |
| RICE HALL JAMES & ASSOCIATES, LLC | 10/16/2025 | 3.43 M | $27.07 M | 24.43% | 1.12% |
| NORTHERN TRUST CORP | 11/14/2025 | 3.34 M | $26.30 M | 8.01% | 1.08% |
| MORGAN STANLEY | 11/14/2025 | 3.20 M | $25.21 M | -25.48% | 1.04% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 2.75 M | $21.69 M | 8.01% | 0.89% |
| DEUTSCHE BANK AG\ | 11/13/2025 | 2.48 M | $19.55 M | 95.74% | 0.81% |
| BLACKSTONE INC. | 11/14/2025 | 2.47 M | $19.44 M | 0.00% | 0.80% |
| JANUS HENDERSON GROUP PLC | 11/14/2025 | 2.47 M | $19.43 M | -10.45% | 0.80% |
| GRANITE INVESTMENT PARTNERS, LLC | 11/10/2025 | 2.12 M | $16.70 M | -1.97% | 0.69% |
| JPMORGAN CHASE & CO | 11/26/2025 | 2.12 M | $16.68 M | -4.26% | 0.69% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 11/13/2025 | 2.08 M | $16.35 M | -6.22% | 0.67% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 11/13/2025 | 2.02 M | $15.91 M | 9.80% | 0.66% |
| IRON TRIANGLE PARTNERS LP | 11/14/2025 | 1.97 M | $15.53 M | 100.00% | 0.64% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2025 | 1.95 M | $15.35 M | -0.66% | 0.63% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 1.94 M | $15.31 M | -3.50% | 0.63% |
| ASSENAGON ASSET MANAGEMENT S.A. | 10/07/2025 | 1.85 M | $14.57 M | -47.69% | 0.60% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 1.82 M | $14.32 M | 45.32% | 0.59% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2025 | 1.75 M | $13.79 M | -49.53% | 0.57% |
| UBS GROUP AG | 11/13/2025 | 1.73 M | $13.64 M | 2.22% | 0.56% |
| PROSIGHT MANAGEMENT, LP | 11/14/2025 | 1.71 M | $13.47 M | -50.88% | 0.56% |
| PARKMAN HEALTHCARE PARTNERS LLC | 11/14/2025 | 1.69 M | $13.30 M | 177.23% | 0.55% |
| ORBIMED ADVISORS LLC | 11/14/2025 | 1.65 M | $12.97 M | -28.00% | 0.53% |
| PANAGORA ASSET MANAGEMENT INC | 11/13/2025 | 1.45 M | $11.42 M | 0.32% | 0.47% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2025 | 1.38 M | $10.85 M | 226.46% | 0.45% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2025 | 1.36 M | $10.75 M | 2,876.62% | 0.44% |
| JANE STREET GROUP, LLC | 11/14/2025 | 1.31 M | $10.35 M | 139.30% | 0.43% |
| STEPHENS INVESTMENT MANAGEMENT GROUP LLC | 10/28/2025 | 1.26 M | $9.93 M | 51.40% | 0.41% |
| WOODLINE PARTNERS LP | 11/14/2025 | 1.11 M | $8.75 M | -53.47% | 0.36% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 10/23/2025 | 1.08 M | $8.54 M | 7.13% | 0.35% |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 11/14/2025 | 1.08 M | $8.47 M | -14.61% | 0.35% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Amicus Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 416 institutional investors and hedge funds held shares of Amicus Therapeutics, Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 29.53 M
WELLINGTON MANAGEMENT GROUP LLP: 28.63 M
BlackRock, Inc.: 25.85 M
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC: 15.75 M
Avoro Capital Advisors LLC: 15.03 M
MILLENNIUM MANAGEMENT LLC: 11.81 M
101.46% of Amicus Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 388.86 M shares in the last 24 months. This purchase volume represents approximately $3.19 B in transactions.